Azalea Therapeutics - Latest News and Information
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Technology Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Sunday recap

NewsDealsSocialBlogsVideosPodcasts
HomeAzalea Therapeutics
Azalea Therapeutics logo

Azalea Therapeutics

0 followers

About Azalea Therapeutics

Azalea Therapeutics is a biotechnology company based in Berkeley, California that develops precision genomic medicines by delivering genome‑editing tools directly to patient cells in vivo. Using its proprietary Envelope Delivery Vehicles (EDVs), the firm programs a patient’s own T cells inside the body to create cancer immunotherapies, aiming to simplify and scale cell‑based treatments.

Recent News

No recent news for this company.

Recent Deals

Key Facts

HQ Location

Berkeley, United States

Employees

Unknown

Status

Private

Website

https://azaleatx.com